Literature DB >> 12453415

NFATc2-mediated repression of cyclin-dependent kinase 4 expression.

Shairaz Baksh1, Hans R Widlund, Ashley A Frazer-Abel, Jinyan Du, Susan Fosmire, David E Fisher, James A DeCaprio, Jaime F Modiano, Steven J Burakoff.   

Abstract

The calcineurin-regulated transcription factor, nuclear factor of activated T cells (NFAT), controls many aspects of T cell function. Here, we demonstrate that the calcineurin/NFAT pathway negatively regulates the expression of cyclin-dependent kinase 4 (CDK4). A canonical NFAT binding site was identified and found to be sensitive to calcium signals, FK506/CsA, and histone deacetylase activity and to not require AP-1. Ectopic expression of NFATc2 inhibited the basal activity of the human CDK4 promoter. Additionally, both calcineurin Aalpha(-/-) and NFATc2(-/-) mice had elevated protein levels of CDK4, confirming a negative regulatory role for the calcineurin/NFAT pathway. This pathway may thus regulate the expression of CDK4 at the transcriptional level and control how cells re-enter a resting, nonproliferative state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453415     DOI: 10.1016/s1097-2765(02)00701-3

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  66 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

2.  NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.

Authors:  Leonardo K Teixeira; Nina Carrossini; Cristiane Sécca; José E Kroll; Déborah C DaCunha; Douglas V Faget; Lilian D S Carvalho; Sandro J de Souza; João P B Viola
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

3.  RSK2 mediates muscle cell differentiation through regulation of NFAT3.

Authors:  Yong-Yeon Cho; Ke Yao; Ann M Bode; H Robert Bergen; Benjamin J Madden; Sang-Muk Oh; Svetlana Ermakova; Bong Seok Kang; Hong Seok Choi; Jung-Hyun Shim; Zigang Dong
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

4.  Minocycline suppresses activation of nuclear factor of activated T cells 1 (NFAT1) in human CD4+ T cells.

Authors:  Gregory L Szeto; Joel L Pomerantz; David R M Graham; Janice E Clements
Journal:  J Biol Chem       Date:  2011-01-31       Impact factor: 5.157

5.  Induced JunD in intestinal epithelial cells represses CDK4 transcription through its proximal promoter region following polyamine depletion.

Authors:  Lan Xiao; Jaladanki N Rao; Tongtong Zou; Lan Liu; Bernard S Marasa; Jie Chen; Douglas J Turner; Antonino Passaniti; Jian-Ying Wang
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

6.  NFATc1 balances quiescence and proliferation of skin stem cells.

Authors:  Valerie Horsley; Antonios O Aliprantis; Lisa Polak; Laurie H Glimcher; Elaine Fuchs
Journal:  Cell       Date:  2008-01-25       Impact factor: 41.582

7.  Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development.

Authors:  Martin R Müller; Yoshiteru Sasaki; Irena Stevanovic; Edward D Lamperti; Srimoyee Ghosh; Sonia Sharma; Curtis Gelinas; Derrick J Rossi; Matthew E Pipkin; Klaus Rajewsky; Patrick G Hogan; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

8.  Activity-dependent repression of muscle genes by NFAT.

Authors:  Zaheer A Rana; Kristian Gundersen; Andres Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

Review 9.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

10.  NFATc1 targets cyclin A in the regulation of vascular smooth muscle cell multiplication during restenosis.

Authors:  Manjula Karpurapu; Dong Wang; Nikhlesh K Singh; Quanyi Li; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.